3
Announcements
Trials
Browse
Landscape
Phase
Phase NA
1
Status
Terminated
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
Gastrointestinal
1
Conditions
Liver Neoplasms
1
Hemorrhage
1
Blood Loss, Surgical
1
Interventions
Sorafenib
12
Radiosurgery
5
Gemcitabine
5
Capecitabine
5
Bevacizumab
5
Radiotherapy
4
Fluorouracil
4
Doxorubicin
4
Sunitinib
3
Oxaliplatin
3
Nivolumab
3
Magnetic Resonance Spectroscopy
3
seocalcitol
2
regorafenib
2
phosphomannopentaose sulfate
2
atezolizumab
2
Thiotepa
2
Radiofrequency Ablation
2
Melphalan
2
Ifosfamide
2
Granulocyte Colony-Stimulating Factor
2
Fluorodeoxyglucose F18
2
Filgrastim
2
Dexamethasone
2
Cisplatin
2
Chemoembolization, Therapeutic
2
Carboplatin
2
Busulfan
2
Brachytherapy
2
Blood Specimen Collection
2
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Terminated
×
Liver Neoplasms
×
Neuromuscular Blockade
×
Clear all
NCT04609410
2025-08-07
MODELS
Università Vita-Salute San Raffaele
Phase NA
Terminated
48 enrolled